IMPORTANCE Circadian dysfunction may be associated with the symptoms and neurodegeneration in Parkinson disease (PD), multiple system atrophy (MSA), and progressive supranuclear palsy (PSP), although the underlying neuroanatomical site of disruption and pathophysiological mechanisms are not fully understood.
A lmost all physiological functions in humans show circadian rhythms. The suprachiasmatic nucleus (SCN) of the hypothalamus acts as a central biological clock, and melatonin (produced by the pineal gland) is its main humoral efferent ( Figure 1) . 2 Good synchronization of circadian rhythms is essential for optimal physical and mental health, and their disruption has been associated with neurodegeneration. 3 Abnormalities in circadian activity, including melatonin secretion, 4, 5 are considered to be associated with some of the symptoms in patients with Parkinson disease (PD), such as disruption of the sleep-wake cycle, fluctuations of rest/motor activity, and neuroendocrine and autonomic functions. 1 However, the neuroanatomical site of disruption remains unknown, and the underlying pathophysiological mechanisms are not fully understood. Impairment of circadian function may also be associated with the clinical fluctuations of autonomic symptoms in multiple system atrophy (MSA) [6] [7] [8] [9] and progressive supranuclear palsy (PSP), [9] [10] [11] although direct evidence involving circadian function markers is lacking. The aim of this study was to provide a histopathological analysis of the key central structures of the circadian system in patients with PD, MSA, and PSP to investigate the underlying mechanisms of circadian dysfunction.
Methods
In this neuropathological case-control study, healthy controls and cases with a neuropathological diagnosis of PD, MSA, and PSP were selected from the archives of the Queen Square Brain Bank for Neurological Disorders (n = 62) and the Parkinson's UK Brain Bank (n = 10) in London, United Kingdom. The donation programs have research ethics committee approval, and written informed consent is obtained for all donations.
Postmortem formalin-fixed hypothalamic and pineal tissue was sampled, and 8-μm-thick sections were stained using standard protocols. Because the SCN cannot be confidently identified with routine staining, vasointestinal peptide (VIP) immunohistochemistry (1:80, ab8556; Abcam) was used to identify specific VIP-expressing neurons, which have a major role in circadian regulation. 12 Cases were excluded if neither SCN nor pineal tissue was available. Because of limited tissue availability, the following total samples were examined in a semiquantitative histologic analysis: 5 SCNs and 7 pineal glands in the control group, 13 SCNs and 17 pineal glands in the PD group, 5 SCNs and 6 pineal glands in the MSA group, and 5 SCNs and 19 pineal glands in the PSP group (Table) .
Key Points
Question What structures of the circadian system are impaired in Parkinson disease, multiple system atrophy, and progressive supranuclear palsy?
Findings In a brain bank case-control study (12 healthy controls, 28 Parkinson disease, 11 multiple system atrophy, and 21 progressive supranuclear palsy), a semiquantitative histologic analysis showed disease-related neuropathological inclusions in the suprachiasmatic nucleus in Parkinson disease and progressive supranuclear palsy samples, without involvement of the pineal gland. Both structures were preserved in healthy control and multiple system atrophy samples.
Meaning Direct histologic involvement of the suprachiasmatic nucleus may explain circadian dysfunction in Parkinson disease and progressive supranuclear palsy but not in multiple system atrophy, which might have important therapeutic implications. Immunohistochemistry for α-synuclein (1:50; Vector) and phosphorylated tau (1:600, AT8; Source BioScience) was performed. Lewy pathology (Lewy bodies and Lewy neurites) among PD cases, glial cytoplasmic inclusions among MSA cases, and PSP-related tau inclusions among PSP cases were assessed using a standard semiquantitative scoring system (absent, mild, moderate, severe, or very severe) in the SCN and pineal gland by an experienced neuropathologist (J.L.H.) ( Figure 2) . Braak stage (range, 0-6) and a Lewy pathology subtype (brainstem, limbic, or neocortical) was assigned for each PD case. Kruskal-Wallis test was used for global comparisons, and Mann-Whitney test was used for pairwise comparisons. Results were not adjusted for multiple comparisons given the exploratory nature of the study, and results were considered statistically significant at 2-tailed P < .05. A software program (Stata, version 12; StataCorp LP) was used for statistical analyses.
Results
In total, 12 healthy controls, 28 PD, 11 MSA, and 21 PSP samples from consecutive brain donations (July 1, 2010, to June 30, 2016) were included in the study. Demographic and clinical characteristics are listed in the Table. The study groups did not differ by sex. The MSA and PSP patients were younger than the controls at the time of death and PD patients, and survival was shorter among the MSA and PSP patients compared with the PD patients (see the Table for statistical comparisons) .
Among PD cases, Lewy pathology was demonstrated in 9 cases in the SCN with mild or moderate severity but in none of the controls. By contrast, mild α-synuclein deposition was found in only 2 pineal glands among PD cases (Table) . Suprachiasmatic nucleus α-synuclein deposition was not associated with the extent and severity of Lewy pathology in the central nervous system analyzed by either Braak stage or Lewy pathology subtype.
Among PSP cases, the SCN showed PSP-related tau pathology of mild or moderate severity in all cases, but no tau pathology was found in pineal tissue. By contrast, MSA cases did not show any α-synuclein deposition in either the SCN or the pineal gland (Table) .
Discussion
To our knowledge, this is the first histologic analysis of the key regulatory structures of the circadian system in parkinsonian disorders. Our study demonstrated different patterns of neuropathological involvement of the circadian system in PD, MSA, and PSP. While circadian dysfunction is likely to be caused by direct involvement with disease-related protein inclusions affecting the central circadian pacemaker (SCN) in PD and PSP but not the pineal gland, neither of these structures was similarly involved in MSA. We found no association between SCN α-synuclein deposition and histologic progression in the central nervous system among patients with PD, although most of them were in an advanced stage of the disease, as expected in a brain bank series. Because of the retrospective nature of the study, we were unable to perform quantitative assessment of specific neuronal populations.
We previously demonstrated histologic involvement of the hypothalamus in patients with PD, 13 but to date the SCN has not been assessed in PD or PSP. The pineal gland was unaffected by tau pathology in all PSP cases herein, and only mild α-synuclein deposition in the form of Lewy neurites was found in pineal tissue in 2 PD patients. To our knowledge, pineal gland tissue has been analyzed previously in only 3 patients with PD, and no Lewy bodies were found. 14 However, Lewy pathology may have been underestimated because sensitive α-synuclein immunohistochemistry was not available at the time of that study.
In contrast with PD, the SCN and pineal gland seem to be spared from α-synuclein deposition in MSA. Previous studies [6] [7] [8] have shown fluctuations of symptoms and body functions in patients with MSA, which could be explained in part by circadian abnormalities, although no studies to date have directly assessed markers of circadian function. Our results do not support involvement of the circadian system by α-synuclein inclusions in MSA, and it seems that circadian dysfunction in these patients may be secondary to degeneration of other systems, such as autonomic networks. Previous pathological studies have shown loss of vasopressin neurons in the SCN of patients with MSA, 6 although vasopressin neurons are more involved in autonomic control, while circadian rhythm regulation is exerted by VIP-expressing neurons.
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In addition to its contribution to some of the symptoms in PD and PSP, circadian disruption has been linked to mechanisms involved in neurodegeneration (eg, regulation of oxidative stress, protein degradation, autophagy, mitochondrial dysfunction, DNA repair, and brain metabolism), and it has been proposed that circadian disruption could also influence the pathological process in neurodegenerative conditions. 15 These findings are of importance because restoring a normal circadian activity by therapeutic interventions could potentially represent a novel target for symptomatic and diseasemodifying interventions. 3 
Limitations
A clinical correlation of the histologic findings could have provided a better understanding of the mechanisms underlying circadian dysfunction. Clinical assessment of circadian function requires strict protocols and control of external factors. However, only routinely collected clinical data were available for our patients.
Conclusions
We have shown neuropathological changes in the SCN but not the pineal gland in the circadian system in patients with PD and PSP, while both structures are preserved in MSA. These findings may reflect different pathophysiological mechanisms of circadian dysfunction, which may have important therapeutic implications.
